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Abstract
We describe the genome sequence of the protist Trichomonas vaginalis, a sexually transmitted human
pathogen. Repeats and transposable elements comprise about two-thirds of the ~160-megabase
genome, reflecting a recent massive expansion of genetic material. This expansion, in conjunction
with the shaping of metabolic pathways that likely transpired through lateral gene transfer from
bacteria, and amplification of specific gene families implicated in pathogenesis and phagocytosis of
host proteins may exemplify adaptations of the parasite during its transition to a urogenital
environment. The genome sequence predicts previously unknown functions for the hydrogenosome,
which support a common evolutionary origin of this unusual organelle with mitochondria.
Trichomonas vaginalis is a flagellated protist that causes trichomoniasis, a common but
overlooked sexually transmitted human infection, with ~170 million cases occurring annually
worldwide (1). The extracellular parasite resides in the urogenital tract of both sexes and can
cause vaginitis in women and urethritis and prostatitis in men. Acute infections are associated
with pelvic inflammatory disease, increased risk of human immunodeficiency virus 1 (HIV-1)
infection, and adverse pregnancy outcomes. T. vaginalis is a member of the parabasilid lineage
of microaerophilic eukaryotes that lack mitochondria and peroxisomes but contain unusual
organelles called hydrogenosomes. Although previously considered to be one of the earliest
branching eukaryotic lineages, recent analyses leave the evolutionary relationship of
parabasalids to other major eukaryotic groups unresolved (2,3). In this article, we report the
draft sequence of T. vaginalis, the first parabasalid genome to be described.
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Genome structure, RNA processing, and lateral gene transfer
The T. vaginalis genome sequence, generated using whole-genome shotgun methodology,
contains 1.4 million shotgun reads assembled into 17,290 scaffolds at ~7.2× coverage (4). At
least 65% of the T. vaginalis genome is repetitive (table S1). Despite several procedures
developed to improve the assembly (4), the superabundance of repeats resulted in a highly
fragmented sequence, preventing investigation of T. vaginalis genome architecture. The repeat
sequences also hampered measurement of genome size, but we estimate it to be ~160 Mb (4).
A core set of ~60,000 protein-coding genes was identified (Table 1), endowing T. vaginalis
with one of the highest coding capacities among eukaryotes (table S2). Introns were identified
in 65 genes, including the ~20 previously documented (5). Transfer RNAs (tRNAs) for all 20
amino acids were found, and ~250 ribosomal DNA (rDNA) units were identified on small
contigs and localized to one of the six T. vaginalis chromosomes (Fig. 1).
The Inr promoter element was found in ~75% of 5′ untranslated region (UTR) sequences (4),
supporting its central role in gene expression (6). Intriguingly, the eukaryotic transcription
machinery of T. vaginalis appears more metazoan than protistan (table S3 to S5). The presence
of a T. vaginalis Dicer-like gene, two Argonaute genes, and 41 transcriptionally active DEAD-
DEAH-box helicase genes suggests the existence of an RNA interference (RNAi) pathway
(fig. S1). Identification of these components raises the possibility of using RNAi technology
to manipulate T. vaginalis gene expression.
During genome annotation, we identified 152 cases of possible prokaryote-to-eukaryote lateral
gene transfer (LGT) [tables S6 and S7 and Supporting Online Material (SOM) text],
augmenting previous reports of conflicting phylogenetic relationships among several enzymes
(7). The putative functions of these genes are diverse, affecting various metabolic pathways
(fig. S2) and strongly influencing the evolution of the T. vaginalis metabolome. A majority
(65%) of the 152 LGT genes encode metabolic enzymes, more than a third of which are
involved in carbohydrate or amino acid metabolism (Fig. 2). Several LGT genes may have
been acquired from Bacteroidetes-related bacteria, which are abundant among vertebrate
intestinal flora (fig. S3).
Repeats, transposable elements, and genome expansion
The most common 59 repeat families identified in the assembly (4) constitute ~39 Mb of the
genome and can be classified as (i) virus-like; (ii) transposon-like, including ~1000 copies of
the first mariner element identified outside animals (8); (iii) retrotransposon-like; and (iv)
unclassified (Table 2). Most of the 59 repeats are present in hundreds of copies (average copy
number ~660) located on small (1- to 5-kb) contigs, and each repeat family is extraordinarily
homogenous, with an average polymorphism of ~2.5%.
The lack of a strong correlation between copy number and average pairwise difference between
copies (fig. S4) suggests that a sudden expansion of the repeat families had occurred. To
estimate the time of expansion, we compared the degree of polymorphism among T.
vaginalis repeats to the divergence between T. vaginalis and its sister taxon T. tenax, a
trichomonad of the oral cavity (9), for several protein-coding loci (4). Our results indicate that
repeat family amplification occurred after the two species split (table S8). Several families
have also undergone multiple expansions, as implied by bi- or trimodal distribution of pairwise
distances between copies (fig. S5). T. vaginalis repeat families appear to be absent in T.
tenax but are present in geographically diverse T. vaginalis (4), consistent with the expansion
having occurred after speciation but before diversification of T. vaginalis.
The large genome size, high repeat copy number, low repeat polymorphism, and evidence of
repeat expansion after T. vaginalis and T. tenax diverged suggest that T. vaginalis has
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undergone a very recent and substantial increase in genome size. To determine whether the
genome underwent any large-scale duplication event(s), we analyzed age distributions of gene
families with five or fewer members (4). A peak in the age distribution histogram of pairs of
gene families was observed (fig. S6), indicating that the genome underwent a period of
increased duplication, and possibly one or more large-scale genome duplication events.
Metabolism, oxidative stress, and transport
T. vaginalis uses carbohydrate as a main energy source via fermentative metabolism under
aerobic and anaerobic conditions. We found the parasite to use a variety of amino acids as
energy substrates (Fig. 2) (10), with arginine dihydrolase metabolism a major pathway for
energy production (fig. S7) (11). We confirmed a central role for aminotransferases (Fig. 2 and
table S9) and glutamate dehydrogenase as indicated previously (12,13); these pathways are
likely catabolic but may be reversible to allow the parasite to synthesize glutamate, aspartate,
alanine, glutamine, and glycine. Genes required for synthesis of proline from arginine (fig. S7)
and for threonine metabolism (fig. S8) were identified. We also identified a de novo
biosynthesis pathway for cysteine via cysteine synthase, an LGT candidate (fig. S8) (14), and
genes encoding enzymes involved in methionine metabolism, including its possible
regeneration (fig. S9).
Earlier studies indicated that de novo lipid biosynthesis in T. vaginalis is confined to the major
phospholipid phosphatidylethanolamine (PE) (15), whereas other lipids, including cholesterol,
are likely acquired from exogenous sources. We found an absence of several essential enzyme-
encoding genes in the synthesis and degradation pathways of nearly all lipids (4), in contrast
to the PE synthetic pathway, which appears complete; however, experimental verification of
these results is required.
T. vaginalis is microaerophilic with a primarily anaerobic life style and thus requires redox
and antioxidant systems to counter the detrimental effects of oxygen. Genes encoding a range
of defense molecules, such as superoxide dismutases, thioredoxin reductases, peroxiredoxins,
and rubrerythrins, were identified (table S10).
T. vaginalis demonstrates a broad range of transport capabilities, facilitated by expansion of
particular transporter families, such as those for sugar and amino acids (table S11). The parasite
also possesses more members of the cation-chloride cotransporter (CCC) family than any other
sequenced eukaryote, likely reflecting osmotic changes faced by the parasite in a mucosal
environment.
None of the proteins required for glycosyl-phosphatidylinositol (GPI)-anchor synthesis were
identified in the genome sequence, making T. vaginalis the first eukaryote known to lack an
apparent GPI-anchor biosynthetic pathway. Whether T. vaginalis has evolved an unusual
biosynthetic pathway for synthesis of its nonprotein lipid anchors, such as the inositol-
phosphoceramide of surface lipophosphoglycans (16), remains to be determined.
Massively expanded gene families
Many gene families in the T. vaginalis genome have undergone expansion on a scale
unprecedented in unicellular eukaryotes (Table 3). Such “conservative” gene family
expansions are likely to improve an organism’s adaptation to its environment (17). Notably,
the selective expansion of subsets of the membrane trafficking machinery, critical for secretion
of pathogenic proteins, endocytosis of host proteins, and phagocytosis of bacteria and host cells
(table S12), correlates well with the parasite’s active endocytic and phagocytic life-style.
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Massively amplified gene families also occur in the parasite’s kinome, which comprises ~880
genes (SOM text) encoding distinct eukaryotic protein kinases (ePKs) and ~40 atypical protein
kinases, making it one of the largest eukaryotic kinomes known. The parasite has heterotrimeric
guanine nucleotide–binding proteins and components of the mitogen-activated protein kinase
(MAPK) pathway, suggesting yeast-like signal transduction mechanisms. Unusually, the T.
vaginalis kinome contains 124 cytosolic tyrosine kinase–like (TKL) genes, yet completely
lacks receptor serine/threonine ePKs of the TKL family. Inactive kinases were found to make
up 17% of the T. vaginalis kinome (table S13); these may act as substrates and scaffolds for
assembly of signaling complexes (18). ePK accessory domains are important for regulating
signaling pathways, but just nine accessory domain types were identified in 8% (72/883) of
the T. vaginalis ePKs (table S14), whereas ~50% of human ePKs contain at least 1 of 83
accessory domain types. This suggests that regulation of protein kinase function and cell
signaling in T. vaginalis is less complex than that in higher eukaryotes, a possible explanation
for the abundance of T. vaginalis ePKs.
T. vaginalis possesses several unusual cyto-skeletal structures: the axostyle, the pelta, and the
costa (19). Most actin- and tubulin-related components of the cytoskeleton are present (table
S15), with the exception of homologs of the actin motor myosin. In contrast, homologs of the
microtubular motors kinesin and dynein are unusually abundant (Table 3). Thus, T. vaginalis
intracellular transport mechanisms are mediated primarily by kinesin and cytoplasmic dynein,
as described for Dictyo-stelium and filamentous fungi, raising the possibility that the loss of
myosin-driven cytoplasmic transport is not uncommon in unicellular eukaryotes (20). Whether
the structural remodeling of amoeboid T. vaginalis during host colonization (see below) is
actin-based, as described for other eukaryotes, or driven by novel cytoskeletal rearrangements
remains an open question.
We identified homologs of proteins involved in DNA damage response and repair, chromatin
restructuring, and meiosis, the latter a process not thought to occur in the parasite (table S16).
Of the 29 core meiotic genes found, several are general repair proteins required for meiotic
progression in other organisms (21), and eight are meiosis-specific proteins. Thus, T.
vaginalis contains either recent evolutionary relics of meiotic machinery or genes functional
in meiotic recombination in an as-yet undescribed sexual cycle.
Molecular mechanisms of pathogenesis
T. vaginalis must adhere to host cells to establish and maintain an infection. A dense glycocalyx
composed of lipophosphoglycan (LPG) (Fig. 3) and surface proteins has been implicated in
adherence (22), but little is known about this critical pathogenic process. We identified genes
encoding enzymes predicted to be required for LPG synthesis (table S17). Of particular interest
are the genes required for synthesis of an unusual nucleotide sugar found in T. vaginalis LPG,
the monosaccharide rhamnose, which is absent in the human host, making it a potential drug
target. Genes (some of which are LGT candidates) were identified that are involved in sialic
acid biosynthesis, consistent with the reported presence of this sugar on the parasite surface
(23).
We identified eight families containing ~800 proteins (4) that represent candidate surface
molecules (Fig. 3 and table S18), including ~650 highly diverse BspA-like proteins
characterized by the Treponema pallidum leucine-rich repeat, TpLLR. BspA-like proteins are
expressed on the surface of certain pathogenic bacteria and mediate cell adherence and
aggregation (24). The only other eukaryote known to encode BspA-like proteins, the mucosal
pathogen Entamoeba histolytica (25), contains 91 such proteins, one of which was recently
localized to the parasite surface (26).
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There are >75 T. vaginalis GP63-like proteins, homologs of the most abundant surface proteins
of Leishmania major, the leishmanolysins, which contribute to virulence and pathogenicity
through diverse functions in both the insect vector and the mammalian host (27). Most T.
vaginalis GP63-like genes possess the domains predicted to be required for a catalytically
active metallopeptidase, including a short HEXXH motif (28) (Fig. 3). Unlike trypanosomatid
GP63 proteins, which are predicted to be GPI-anchored, most T. vaginalis GP63-like proteins
have a predicted C-terminal transmembrane domain as a putative cell surface anchor, consistent
with the apparent absence of GPI-anchor biosynthetic enzymes. Other T. vaginalis protein
families share domains with Chlamydia polymorphic membrane proteins, Giardia lamblia
variant surface proteins, and E. histolytica immunodominant variable surface antigens (Fig. 3
and table S18).
After cytoadherence, the parasite becomes amoeboid, increasing cell-to-cell surface contacts
and forming cytoplasmic projections that interdigitate with target cells (19). We have identified
genes encoding cytolytic effectors, which may be released upon host-parasite contact. T.
vaginalis lyses host red blood cells, presumably as a means of acquiring lipids and iron and
possibly explaining the exacerbation of symptoms observed during menstruation (29). This
hemolysis is dependent on contact, temperature, pH, and Ca2+, suggesting the involvement of
pore-forming proteins (30) that insert into the lipid bilayer of target cells, mediating osmotic
lysis. Consistent with this, we have identified 12 genes (TvSaplip1 to TvSaplip12) containing
saposin-like (SAPLIP) pore-forming domains (fig. S10). These domains show a predicted six-
cysteine pattern and abundant hydrophobic residues in conserved positions while displaying
high sequence variability (fig. S11). The TvSaplips are similar to amoebapore proteins secreted
by E. histolytica and are candidate trichopores that mediate a cytolytic effect.
The degradome
Peptidases perform many critical biological processes and are potential virulence factors,
vaccine candidates, and drug targets (31). T. vaginalis contains an expanded degradome of
more than 400 peptidases (SOM text), making it one of the most complex degradomes
described (table S19). Of the three families of aspartic peptidases (table S20), T. vaginalis
contains a single member of the HIV-1 retropepsin family that might serve as a putative
candidate for anti-HIV peptidase inhibitors. Many studies have implicated papain family
cysteine peptidases as virulence factors in trichomonads; we identified >40 of them,
highlighting the diversity of this family. Cysteine peptidases that contribute to the 20S
proteosome (ubiquitin C-terminal hydrolases) are abundant (117 members, ~25% of the
degradome), emphasizing the importance of cytosolic protein degradation in the parasite. T.
vaginalis has nine NlpC/P60-like members (table S20; several of which are LGT candidates),
which play a role in bacterial cell wall degradation and the destruction of healthy vaginal
microflora, making the vaginal mucosa more sensitive to other infections.
We also identified many subtilisin-like and several rhomboid-like serine peptidases, candidates
for processing T. vaginalis surface proteins. In addition to the first asparaginase-type of
threonine peptidase found in a protist, 13 families of metallopeptidases were also identified,
as well as three cystatin-like proteins, natural peptidase inhibitors, which may regulate the
activity of the abundant papain-like cysteine peptidases (table S20).
The hydrogenosome
Several microaerophilic protists and fungi, including trichomonads and ciliates, lack typical
mitochondria and possess double-membrane hydrogenosomes, which produce adenosine
triphophate (ATP) and molecular hydrogen through fermentation of metabolic intermediates
produced in the cytosol. Although the origin of these organelles has been controversial, most
evidence now supports a common origin with mitochondria (3). Few genes encoding homologs
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of mitochondrial transporters, translocons, and soluble proteins were identified in the T.
vaginalis genome (fig. S12), suggesting that its hydrogenosome has undergone reductive
evolution comparable to other protists whose mitochondrial proteomes are reduced (e.g.,
Plasmodium). Because nuclear-encoded hydrogenosomal matrix proteins are targeted to the
organelle by N-terminal presequences that are proteolytically cleaved upon import (32) similar
to mitochondrial precursor proteins, we screened the genome for consensus 5-to 20-residue
presequences containing ML(S/T/A) X(1...15)R (N/F/E/XF), MSLX(1...15)R(N/F/XF), or MLR
(S/N)F (28) motifs. A total of 138 genes containing putative presequences were identified, 67%
of which are similar to known proteins, primarily ones involved in energy metabolism and
electron-transport pathways (fig. S13 and table S21).
The production of molecular hydrogen, the hallmark of the hydrogenosome, is catalyzed by
an unusually diverse group of iron-only [Fe]-hydrogenases that possess, in addition to a
conserved H cluster, four different sets of functional domains (fig. S14), indicating that
hydrogen production may be more complex than originally proposed. The pathway that
generates electrons for hydrogen (fig. S12) is composed of many proteins encoded by multiple
genes (tables S22 to S24). Our analyses extend the evidence that T. vaginalis hydrogenosomes
contain the complete machinery required for mitochondria-like intraorganellar FeS cluster
formation (33) and also reveal the presence of two putative cytosolic auxiliary proteins,
indicating that hydrogenosomes may be involved in biogenesis of cytosolic FeS proteins. Some
components of FeS cluster assembly machinery have also been found in mitosomes
(mitochondrial remnants) of G. lamblia, supporting a common evolutionary origin of
mitochondria, hydrogenosomes, and mitosomes (3).
A new predicted function of hydrogenosomes revealed by the genome sequence is amino acid
metabolism. We identified two components of the glycine-cleavage complex (GCV), L protein
and H protein. Another component of this pathway is serine hydroxymethyl transferase
(SHMT), which in eukaryotes exists as both cytosolic and mitochondrial isoforms. A single
gene coding for SHMT of the mitochondrial type with a putative N-terminal hydrogenosomal
presequence was identified. Because both GCV and SHMT require folate (fig. S12), which T.
vaginalis apparently lacks, the functionality of these proteins remains unclear.
The 5-nitroimidazole drugs metronidazole (Mz) and tinidazole are the only approved drugs for
treatment of trichomoniasis. These prodrugs are converted within the hydrogenosome to toxic
nitroradicals via reduction by ferredoxin (Fdx) (fig. S12). Clinical resistance to Mz (MzR) is
estimated at 2.5 to 5% of reported cases and rising (34) and is associated with decreases in or
loss of Fdx (35). We identified seven Fdx genes with hydrogenosomal targeting signals (tables
S21 and S25), the redundancy of which provides explanations for the low frequency of MzR
and for why knockout of a single Fdx gene does not lead to MzR (35). Our analyses also provide
clues to the potential mechanisms that clinically resistant parasites may use, such as the
presence of nitroreductase (NimA-like), reduced nicotinamide adenine dinucleotide phosphate
(NADPH)–nitroreductase, and NADH-flavin oxidoreductase genes (tables S23 and S26),
which have been implicated in MzR in bacteria (36,37).
Summary and concluding remarks
Our investigation of the T. vaginalis genome sequence provides a new perspective for studying
the biology of an organism that continues to be ignored as a public health issue despite the high
number of trichomoniasis cases worldwide. The discovery of previously unknown metabolic
pathways, the elucidation of pathogenic mechanisms, and the identification of candidate
surface proteins likely involved in facilitating invasion of human mucosal surfaces provide
potential leads for the development of new therapies and novel methods for diagnosis.
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The analysis presented here of one of the most repetitive genomes known has undoubtedly
been hampered by the sheer number of highly similar repeats and transposable elements. Why
did this genome expand so dramatically in size? We hypothesize that the most recent common
ancestor of T. vaginalis underwent a population bottleneck during its transition from an enteric
environment (the habitat of most trichomonads) to the urogenital tract. During this time, the
decreased effectiveness of selection resulted in repeat accumulation and differential gene
family expansion. Genome size and cell volume are positively correlated (38,39); hence, the
increased genome size of T. vaginalis achieved through rapid fixation of repeat copies could
have ultimately resulted in a larger cell size. T. vaginalis cell volume is greater than that of T.
tenax and related intestinal species Pentratrichomonas hominis (40) and T. gallinae (41), and
it generally conforms to the relationship of genome size to cell volume reported for protists
(41). T. vaginalis is also a highly predatory parasite that phagocytoses bacteria, vaginal
epithelial cells, and host erythrocytes (42) and is itself ingested by macrophages. Given these
interactions, it is tempting to speculate that an increase in cell size could have been selected
for in order to augment the parasite’s phagocytosis of bacteria, to reduce its own phagocytosis
by host cells, and to increase the surface area for colonization of vaginal mucosa.
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Fig. 1.
Karyotype and fluorescent in situ hybridization (FISH) analysis of T. vaginalis chromosomes.
(A) Metaphase chromosome squashes of T. vaginalis reveal six chromosomes (I to VI). (B)
FISH analysis using an 18S rDNA probe shows that all ~250 rDNA units localize to a single
chromosome. (C) In contrast, the Tvmar1 transposable element (8) is dispersed throughout the
genome.
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Fig. 2.
Schematic of T. vaginalis amino acid metabolism. A complete description of enzymatic
reactions (represented as numbers) is given in the SOM text. Broken lines represent enzymes
for which no gene was identified in the genome sequence, although the activity would appear
to be required. Green boxes indicate enzymes encoded by candidate LGT genes.
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Fig. 3.
Structural organization of putative T. vaginalis surface molecules involved in host cell
adherence and cyto-toxicity (28). Candidate surface protein families (a to f) are depicted as
part of the glycocalyx (gray shading), known to be composed of LPG (g). The number of
proteins with an inferred transmembrane domain (red box) is indicated at right, with the size
of the entire family shown in parentheses. Substantial length variation exists between and
within families (proteins are not drawn to scale). Additional information can be found in table
S18.
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Table 1
Summary of the T. vaginalis genome sequence data. Assembly size (bp, base pairs) includes all contigs and
differs from estimated genome size of ~160 Mb (4). The scaffold size is the minimum scaffold length, such that
more than half the genome is contained in scaffolds of at least that length. The number of predicted genes may
include low-complexity repeats or novel transposable elements rather than true T. vaginalis genes, but in the
absence of decisive evidence these remain in the gene set. The number of evidence-supported genes includes
those with either similarity to a known protein (E < 1 × 10−10, >25% length of protein) or similarity to an expressed
sequence tag (>95% identity over >90% length of the gene). A total of 763 rDNA fragments (258 copies of 28S,
254 copies of 18S, and 251 copies of 5.8S) were identified.
Feature Value
Genome
Size of assembly (bp) 176,441,227
G+C content (%) 32.7
No. of scaffolds 17,290
N50 scaffold size (bp) 68,338
Protein-coding genes
No. of predicted genes 59,681
No. of evidence-supported genes 25,949
No. of genes with introns 65
Mean gene length (bp) 928.6
Gene G+C content (%) 35.5
Gene density (bp) 2956
Mean length of intergenic regions (bp) 1165.4
Intergenic G+C content (%) 28.8
Non–protein-coding genes
Predicted tRNA genes 479
Predicted 5.8S, 18S, and 28S rDNA units ~250
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Table 3
Large gene families in T. vaginalis. Only gene families, or aggregates of gene families mediating a given process,
for which there are more than 30 members and that have been assigned a putative function are listed. (See SOM
text for subfamily organization.) The small guano-sine triphosphatases (GTPases) are the sum of Rab and ARF
small GTPases only; all other GTPases are shown in table S12. ABC, ATP-binding cassette; MFS, major
facilitator superfamily; MOP, multi-drug/oligosaccharidyl-lipid/polysaccharide; AAAP, amino acid/auxin
permease.
Gene family (functional unit) Members
Protein kinases 927
BspA-like gene family 658
Membrane trafficking: small GTPases 328
rDNA gene cluster ~250
Cysteine peptidase (clan CA, family C19) 117
Membrane trafficking: vesicle formation 113
ABC transporter superfamily 88
GP63-like (leishmanolysin) 77
MFS transporter family 57
MOP flippase transporter family 47
Cysteine peptidase (clan CA, family C1) 48
AAAP transporter family 40
Dynein heavy chain 35
P-ATPase transporter family 33
Serine peptidase (clan SB, family S8) 33
Membrane trafficking: vesicle fusion 31
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